Century Therapeutics Files 8-K

Ticker: IPSC · Form: 8-K · Filed: Jul 8, 2024 · CIK: 1850119

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory

TL;DR

Century Therapeutics filed an 8-K, mostly procedural stuff, check exhibits for details.

AI Summary

On July 8, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and headquartered in Philadelphia, Pennsylvania.

Why It Matters

This 8-K filing indicates Century Therapeutics is submitting required documentation to the SEC, which may contain updates on financial status or other corporate events.

Risk Assessment

Risk Level: low — The provided text is a standard 8-K filing notification without specific material events or financial disclosures that would indicate immediate risk.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are detailed in this 8-K filing?

The provided text for the 8-K filing does not specify the details of the 'Other Events' beyond listing it as an item information category.

What is the primary purpose of this 8-K filing?

This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily for 'Other Events' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on July 8, 2024.

Where is Century Therapeutics, Inc. headquartered?

Century Therapeutics, Inc. is headquartered at 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104.

What is the company's SIC code?

The Standard Industrial Classification (SIC) code for Century Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-07-08 16:33:41

Key Financial Figures

Filing Documents

01

Item 8.01 Other Events On July 8, 2024, Century Therapeutics, Inc. (the "Company") updated information reflected in a slide presentation, which is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Representatives of the Company will use the updated presentation in various meetings with investors from time to time.

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit No. Document 99.1 Investor Presentation of Century Therapeutics, Inc., dated July 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CENTURY THERAPEUTICS, INC. By: /s/ Brent Pfeiffenberger, Pharm.D. Name: Brent Pfeiffenberger, Pharm.D. Title: President and Chief Executive Officer Date: July 8, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing